EURORDIS Rare Diseases Europe is organising its 32nd Round Table of Companies (ERTC) workshop on the theme of « The impact of the EU regulatory network strategy 2020-2025 on the development of orphan medicines » aimed at bringing together participants spread across pharmaceutical, biotech and clinical research organisations (CRO), patient advocates, regulators, HTA bodies, healthcare professionals, researchers and academics,
The fully online workshop will take place over two days on October 20th – 21st from 14.00 – 18.00 CET.
The workshop aims at gaining insights into the future of the regulatory strategy for data acquisition and analysis. Therefore, a strong emphasis will be placed on presenting and discussing the work of three of the European Medicines Agency (EMA) Task Forces: Clinical Studies and Manufacturing, Data Analytics and Methods, and Regulatory Science & Innovation.
More information and registration here: https://events.eurordis.org/32ertcworkshop/identification?reg_type_id=183905&ref=aca_hcp
